Literature DB >> 2930700

Specific targeting and toxicity of sulphonated aluminium phthalocyanine photosensitised liposomes directed to cells by monoclonal antibody in vitro.

J Morgan1, A G Gray, E R Huehns.   

Abstract

A partially purified fraction of the water soluble photosensitive dye sulphonated aluminium phthalocyanine (AlSPc) was encapsulated in liposomes which were then linked to a targeting monoclonal antibody 791T/36 using a heterobifunctional linking agent. The photocytotoxic effects of the liposomes were determined on two cell lines bearing an antigen with which the targeting antibody binds: 791T, an osteosarcoma and C170, a colorectal carcinoma; and a control cell line not bearing the antigen; DW-BCL, an Epstein-Barr virus immortalised B-cell line. Antibody dependent cytotoxicity was observed in 791T and C170 cells and was proportional to the number of antigens on the cells, the AlSPc concentration and the time of exposure to activating red light. No significant toxicity was seen using untargeted liposomes, control cells or free AlSPc fraction under similar conditions. Targeted cells and controls kept in the dark also showed no significant toxicity. A possible mechanism of action is postulated and simple adaptations which demonstrate the versatility of the model are discussed. Some suggestions as to the clinical situations to which this system might be applied in the form of photodynamic therapy (PDT) are made.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2930700      PMCID: PMC2247071          DOI: 10.1038/bjc.1989.73

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  27 in total

1.  Uptake of antibody directed cytotoxic liposomes by CD3 on human T cells.

Authors:  A G Gray; J Morgan; D C Linch; E R Huehns
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

2.  The preparation and characterisation of 111In-labelled 791T/36 monoclonal antibody for tumour immunoscintigraphy.

Authors:  A C Perkins; M V Pimm; M K Birch
Journal:  Eur J Nucl Med       Date:  1985

3.  Kinetics of divalent monoclonal antibody binding to tumour cell surface antigens using flow cytometry: standardization and mathematical analysis.

Authors:  R Roe; R A Robins; R R Laxton; R W Baldwin
Journal:  Mol Immunol       Date:  1985-01       Impact factor: 4.407

Review 4.  Common epithelial cancer of the ovary (2).

Authors:  G S Richardson; R E Scully; N Nikrui; J H Nelson
Journal:  N Engl J Med       Date:  1985-02-21       Impact factor: 91.245

5.  Colorimetric determination of phospholipids with ammonium ferrothiocyanate.

Authors:  J C Stewart
Journal:  Anal Biochem       Date:  1980-05-01       Impact factor: 3.365

6.  Preparation and properties of a drug-carrier-antibody conjugate showing selective antibody-directed cytotoxicity in vitro.

Authors:  M C Garnett; M J Embleton; E Jacobs; R W Baldwin
Journal:  Int J Cancer       Date:  1983-05-15       Impact factor: 7.396

7.  Differential endocytosis of T and B lymphocyte surface molecules evaluated with antibody-bearing fluorescent liposomes containing methotrexate.

Authors:  P Machy; J Barbet; L D Leserman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

8.  Purification of a trypsin-insensitive fragment of spectrin from human erythrocyte membranes.

Authors:  M Hanspal; G B Ralston
Journal:  Biochim Biophys Acta       Date:  1981-07-28

9.  Synthesis, tissue distribution and tumor uptake of [99Tc]tetrasulfophthalocyanine.

Authors:  J Rousseau; D Autenrieth; J E van Lier
Journal:  Int J Appl Radiat Isot       Date:  1983-03

10.  Liposomes as drug carriers in cancer therapy.

Authors:  J N Weinstein
Journal:  Cancer Treat Rep       Date:  1984-01
View more
  8 in total

1.  Can nanotechnology potentiate photodynamic therapy?

Authors:  Ying-Ying Huang; Sulbha K Sharma; Tianhong Dai; Hoon Chung; Anastasia Yaroslavsky; Maria Garcia-Diaz; Julie Chang; Long Y Chiang; Michael R Hamblin
Journal:  Nanotechnol Rev       Date:  2012-03       Impact factor: 7.848

2.  Targeting of multidrug-resistant human ovarian carcinoma cells with anti-P-glycoprotein antibody conjugates.

Authors:  Kirk D Fowers; Jindřich Kopeček
Journal:  Macromol Biosci       Date:  2012-01-25       Impact factor: 4.979

3.  Impacting Pancreatic Cancer Therapy in Heterotypic in Vitro Organoids and in Vivo Tumors with Specificity-Tuned, NIR-Activable Photoimmunonanoconjugates: Towards Conquering Desmoplasia?

Authors:  Girgis Obaid; Shazia Bano; Srivalleesha Mallidi; Mans Broekgaarden; Jerrin Kuriakose; Zachary Silber; Anne-Laure Bulin; Yucheng Wang; Zhiming Mai; Wendong Jin; Diane Simeone; Tayyaba Hasan
Journal:  Nano Lett       Date:  2019-10-04       Impact factor: 11.189

4.  Peptide-based pharmacomodulation of a cancer-targeted optical imaging and photodynamic therapy agent.

Authors:  Klara Stefflova; Hui Li; Juan Chen; Gang Zheng
Journal:  Bioconjug Chem       Date:  2007-02-14       Impact factor: 4.774

5.  Use of photosensitive, antibody directed liposomes to destroy target populations of cells in bone marrow: a potential purging method for autologous bone marrow transplantation.

Authors:  J Morgan; A J MacRobert; A G Gray; E R Huehns
Journal:  Br J Cancer       Date:  1992-01       Impact factor: 7.640

6.  Low density lipoprotein for delivery of a water-insoluble alkylating agent to malignant cells. In vitro and in vivo studies of a drug-lipoprotein complex.

Authors:  S Vitols; K Söderberg-Reid; M Masquelier; B Sjöström; C Peterson
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

Review 7.  Like a bolt from the blue: phthalocyanines in biomedical optics.

Authors:  Nawal Sekkat; Hubert van den Bergh; Tebello Nyokong; Norbert Lange
Journal:  Molecules       Date:  2011-12-23       Impact factor: 4.411

Review 8.  Photoimmunotherapy of Ovarian Cancer: A Unique Niche in the Management of Advanced Disease.

Authors:  Shubhankar Nath; Mohammad Ahsan Saad; Michael Pigula; Joseph W R Swain; Tayyaba Hasan
Journal:  Cancers (Basel)       Date:  2019-11-27       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.